These changes in expression level are not prognostic but appear to have functional significance; AMPK activation represents a chronic stress adaptation that confers a survival advantage by inducing cellular proliferation and cell cycle progression that is particularly advantageous for the survival of primary glioma stem cells (GSCs) [58,59]. The gene discussed is PRKAA2; the disease is central nervous system cancer.